Echo Therapeutics (ECTE) Posts Wider than Expected Q1 Loss of 8c/Share
Tweet
Share
E-mailGet Alerts ECTE Hot Sheet
Price: $0.00 --0%
Financial Fact:
Interest expense: -133.06K
Today's EPS Names:
MTEX, NSYS, PLNH, More
Financial Fact:
Interest expense: -133.06K
Today's EPS Names:
MTEX, NSYS, PLNH, More
Join SI Premium – FREE
Echo Therapeutics (NASDAQ: ECTE) reported Q1 EPS of ($0.08), $0.01 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $30.93 thousand versus the consensus estimate of $80 thousand.
For earnings history and earnings-related data on Echo Therapeutics (ECTE) click here.
For earnings history and earnings-related data on Echo Therapeutics (ECTE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- Park Dental Partners, Inc. (PARK) Tops Q2 EPS by 28c
- Gaxos.ai Inc. (GXAI) Reports Q2 EPS of $0.02
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
